Diseases and conditions

FILE - This 2014 file electron microscope image made available by the Centers for Disease Control and Prevention shows numerous, spheroid-shaped Enterovirus-D68 (EV-D68) virions. Doctors have suspected a mysterious paralyzing illness, acute flaccid myelitis, might be tied to the virus. This year has seen a record number of cases of the mysterious paralyzing illness in children, U.S. health officials said Monday, Dec. 10, 2018. (Cynthia S. Goldsmith, Yiting Zhang/CDC via AP, File)
December 10, 2018 - 3:41 pm
NEW YORK (AP) — This year has seen a record number of cases of a mysterious paralyzing illness in children, U.S. health officials said Monday. It's still not clear what's causing the kids to lose the ability to move their face, neck, back, arms or legs. The symptoms tend to occur about a week after...
Read More
December 10, 2018 - 1:06 pm
NEW YORK (AP) — Health officials are reporting the most cases ever of a mysterious paralyzing illness in children. Fortunately, the disease remains rare. The Centers for Disease Control and Prevention on Monday reported 158 confirmed cases so far this year. That's more than the 149 reported in a...
Read More
In this Aug. 16, 2010 file photo a nurse looks on from a window of the Giulesti hospital following a fire that left 5 newborn babies dead. Romanian health authorities on Friday, Nov. 30, 2018, temporarily closed the maternity hospital in the capital after over a dozen babies born there recently were diagnosed with a drug-resistant superbug. The Health Ministry said the hospital would stop admissions after the newborns were recently diagnosed with antibiotic-resistant Staphylococcus aureus. (AP Photo/Vadim Ghirda, File)
December 10, 2018 - 11:05 am
BUCHAREST, Romania (AP) — The number of babies diagnosed with a drug-resistant superbug at a maternity hospital in Romania's capital has risen to 39, authorities said Monday. Raluca Alexandru, spokeswoman for Giulesti Maternity hospital, closed Nov. 30 due to the outbreak, said tests have confirmed...
Read More
In this Aug. 16, 2010 file photo a nurse looks on from a window of the Giulesti hospital following a fire that left 5 newborn babies dead. Romanian health authorities on Friday, Nov. 30, 2018, temporarily closed the maternity hospital in the capital after over a dozen babies born there recently were diagnosed with a drug-resistant superbug. The Health Ministry said the hospital would stop admissions after the newborns were recently diagnosed with antibiotic-resistant Staphylococcus aureus. (AP Photo/Vadim Ghirda, File)
December 10, 2018 - 7:38 am
BUCHAREST, Romania (AP) — Romanian authorities say the number of babies diagnosed with a drug-resistant superbug at a maternity hospital in the capital has risen to 39. Raluca Alexandru, spokeswoman for Giulesti Maternity hospital, closed Nov. 30 due to the outbreak, on Monday said tests have...
Read More
December 10, 2018 - 4:59 am
JOHANNESBURG (AP) — The World Health Organization says Ebola vaccinations soon will begin in South Sudan as the country is at "very high risk" in the current outbreak based in neighboring Congo. A statement says South Sudan's health ministry will begin vaccinating some health workers and other...
Read More
Dr. Eden Wells listens as Genesee District Judge William Crawford reads through a prepared statement during a hearing Friday, Dec. 7, 2018, at Genesee District Court in downtown Flint, Mich. Wells, Michigan's chief medical executive, will stand trial on involuntary manslaughter and other charges in a criminal investigation of the Flint water crisis, a judge ruled Friday. (Jake May/The Flint Journal via AP)
December 07, 2018 - 1:21 pm
LANSING, Mich. (AP) — Michigan's chief medical executive will stand trial on involuntary manslaughter and other charges in a criminal investigation of the Flint water crisis, a judge ruled Friday. Dr. Eden Wells is among five people facing an involuntary manslaughter charge in connection to an...
Read More
In this photo taken Sunday, Nov. 4, 2018 and made available Tuesday, Dec. 4, 2018, a caretaker already cured of Ebola is seen carrying a four day old baby suspected of having Ebola into a Medecins Sans Frontieres (MSF) supported Ebola treatment centre in Butembo, Congo. Congo's deadly Ebola outbreak is now the second largest in history, behind the devastating West Africa outbreak that killed thousands a few years ago, according to the World Health Organization. (John Wessels/Medecins Sans Frontieres via AP)
December 07, 2018 - 4:12 am
DAKAR, Senegal (AP) — The second-largest Ebola outbreak in history has spread to a major city in eastern Congo, as health experts worry whether the stock of an experimental vaccine will stand up to the demands of an epidemic with no end in sight. Butembo, with more than 1 million residents, is now...
Read More
December 07, 2018 - 4:06 am
DAKAR, Senegal (AP) — The second-largest Ebola outbreak in history has spread to a major city in eastern Congo, as health experts worry whether the stock of an experimental vaccine will stand up to the demands of an epidemic with no end in sight. Butembo, with more than 1 million residents, is now...
Read More
This image provided by Sandoz Inc. shows a new epinephrine injector by Sandoz, Inc. Amid persistent shortages of EpiPens and other emergency autoinjectors that treat life-threatening allergic reactions, generic drugmaker Sandoz says that early next year it will launch a slightly cheaper rival in the U.S. Sandoz said Thursday, Dec. 6, 2018, that it plans to sell a pair of its generic autoinjectors for $250 without insurance. (Sandoz Inc. via AP)
December 06, 2018 - 7:27 pm
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. The EpiPen injector is used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the...
Read More
This image provided by Sandoz Inc. shows a new epinephrine injector by Sandoz, Inc. Amid persistent shortages of EpiPens and other emergency autoinjectors that treat life-threatening allergic reactions, generic drugmaker Sandoz says that early next year it will launch a slightly cheaper rival in the U.S. Sandoz said Thursday, Dec. 6, 2018, that it plans to sell a pair of its generic autoinjectors for $250 without insurance. (Sandoz Inc. via AP)
December 06, 2018 - 6:01 pm
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year. The penlike injectors are used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which...
Read More

Pages